İnsan çevirisi örneklerinden çeviri yapmayı öğrenmeye çalışıyor.
Profesyonel çevirmenler, işletmeler, web sayfaları ve erişimin serbest olduğu çeviri havuzlarından.
kõrvaltoimed, mida kirjeldati topeltpimeuuringutes patsientidel, kes said vildagliptiini 100 mg ööpäevas monoteraapiana (n=1855)
adverse reactions reported in patients who received vildagliptin 100 mg daily as monotherapy in double-blind studies (n=1855)
Son Güncelleme: 2012-04-11
Kullanım Sıklığı: 2
Kalite:
järgnevalt on organsüsteemi klassi ja absoluutse esinemissageduse järgi loetletud kõrvaltoimed, mida kirjeldati patsientidel, kes said topeltpimeuuringutes vildagliptiini monoteraapia ja täiendava ravimina.
adverse reactions reported in patients who received vildagliptin in double-blind studies as monotherapy and add-on therapies are listed below by system organ class and absolute frequency.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
tabel 4 kõrvaltoimed, mida kirjeldati topeltpimeuuringutes patsientidel, kes said vildagliptiini 100 mg ööpäevas monoteraapiana (n=1855)
table 4 adverse reactions reported in patients who received vildagliptin 100 mg daily as monotherapy in double-blind studies (n=1855)
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
järgnevalt on loetletud iga manustamisviisi kõrvaltoimed organsüsteemi klassi ja absoluutse esinemissageduse järgi, mida kirjeldati patsientidel, kes said topeltpimeuuringutes xiliarx’i monoteraapiana ja täiendava ravina.
adverse reactions reported in patients who received xiliarx in double-blind studies as monotherapy and add-on therapies are listed below for each indication by system organ class and absolute frequency.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
tabel 1 kõrvaltoimed, mida kirjeldati topeltpimeuuringutes galvus’t 100 mg üks kord päevas kombineeritult metformiiniga saanud patsientidel (n=208)
table 1 adverse reactions reported in patients who received galvus 100 mg daily in combination with metformin in double-blind studies (n=208)
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
tabel 1 kõrvaltoimed, mida kirjeldati topeltpimeuuringutes patsientidel, kes said vildagliptiini 100 mg ööpäevas täiendava ravimina lisaks metformiinile võrreldes platseebo pluss metformiini kasutamisega (n=208)
table 1 adverse reactions reported in patients who received vildagliptin 100 mg daily as add-on therapy to metformin compared to placebo plus metformin in double-blind studies (n=208)
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
proquadis sisalduvate leetrite, mumpsi ja punetiste komponentide efektiivsus on kindlaks tehtud kontrollitud topeltpimeuuringutes, kus kasutati merck & co., inc. poolt toodetud ühevalentseid vaktsiine ja demonstreeriti väga efektiivset kaitsetoimet.
efficacy of the measles, mumps, and rubella components of proquad was previously established in a series of double-blind controlled field trials with the monovalent vaccines manufactured by merck & co., inc., which demonstrated a high degree of protective efficacy.
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 1
Kalite:
Uyarı: Görünmez HTML biçimlendirmesi içeriyor
rosiglitasooni kliinilistes topeltpimeuuringutes oli alat aktiivsuse suurenemise (> 3x normivahemiku ülempiirist) esinemissagedus võrdne platseeboga (0,2%) ning väiksem kui aktiivsete võrdlusravimite puhul (0,5% metformiini/sulfonüüluurea derivaatide puhul).
in double-blind clinical trials with rosiglitazone the incidence of elevations of alt greater than three times the upper limit of normal was equal to placebo (0.2%) and less than that of the active comparators (0.5% metformin/sulphonylureas).
Son Güncelleme: 2017-04-26
Kullanım Sıklığı: 3
Kalite:
Uyarı: Görünmez HTML biçimlendirmesi içeriyor